Biomea Fusion, Inc. (BMEA) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $100 million, Biomea Fusion, Inc. is a micro-cap company. The stock currently trades at $1.36, down 0.73% today, with a 52-week range of $0.87–$3.08.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.81 | $-0.81 | +17.3% | |
| 2023 | $-0.98 | $-0.98 | -14.0% | |
| 2022 | $-0.86 | $-0.86 | — | |
| 2021 | — | — | — |